Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy QinetiQ Group (QQ.) by Tom Winnifrith in ShareProphets
- Buy QinetiQ Group (QQ.) by Steve Moore in ShareProphets
- Avoid Portmeirion Group (PMP) by Steve Moore in ShareProphets
- Sell Haleon (HLN) by Deutsche Bank
- Buy Mears Group (MER) by Deutsche Bank
- Buy QinetiQ Group (QQ.) by Deutsche Bank
- Buy Sainsbury (J) (SBRY) by Deutsche Bank
- Buy Foresight Group Holdings Limited NPV (FSG) by Deutsche Bank
- Hold JD Sports Fashion (JD.) by Shore Capital
- Hold Cohort (CHRT) by Jefferies
- Buy Avon Technologies (AVON) by Jefferies
- Hold QinetiQ Group (QQ.) by Jefferies
- Hold Sainsbury (J) (SBRY) by Jefferies
- Hold Smiths Group (SMIN) by Jefferies
- Underperform Associated British Foods (ABF) by Jefferies
- Hold B&M European Value Retail S.A. (DI) (BME) by Jefferies
- Sell Maintel Holdings (MAI) by Steve Moore in ShareProphets
- Buy Compass Group (CPG) by Jefferies
- Buy LBG Media (LBG) by Berenberg
- Buy Devolver Digital, Inc. (DI) Reg S Cat 3/144A (DEVO) by Berenberg
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,273 open tips for AstraZeneca (AZN)
| Latest Bid : 13,922.00p | Latest Ask : 13,926.00p |
| High Today : 14,232.00p | Low Today : 13,838.00p |
| This Years High : 15,316.00p | This Years Low : 10,204.00p |
| Volume : 809,500 | MKT Cap : £214737M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Goldman Sachs | Premium Only | 2026-07-01 09:41:00 01/07/2026 | -2.46% |
| Buy | Jefferies | Premium Only | 2026-06-26 15:30:00 26/06/2026 | -3.08% |
| Add | Simon Watkins | Premium Only | 2026-06-23 07:10:00 23/06/2026 | 3.48% |
| Sell | Deutsche Bank | Premium Only | 2026-06-02 11:00:00 02/06/2026 | -3.88% |
| Buy | Jefferies | Premium Only | 2026-05-13 12:46:00 13/05/2026 | 1.58% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 13,922.00p | Latest Ask : 13,926.00p |
| High Today : 14,232.00p | Low Today : 13,838.00p |
| This Years High : 15,316.00p | This Years Low : 10,204.00p |
| Volume : 809,500 | MKT Cap : £214737M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Goldman Sachs | Premium Only | 2026-07-01 09:41:00 01/07/2026 | -2.46% |
| Buy | Jefferies | Premium Only | 2026-06-26 15:30:00 26/06/2026 | -3.08% |
| Add | Simon Watkins | Premium Only | 2026-06-23 07:10:00 23/06/2026 | 3.48% |
| Sell | Deutsche Bank | Premium Only | 2026-06-02 11:00:00 02/06/2026 | -3.88% |
| Buy | Jefferies | Premium Only | 2026-05-13 12:46:00 13/05/2026 | 1.58% |